Status:
UNKNOWN
Split-Face Study Comparing Botox and Jeuveau in Treating Glabellar Lines
Lead Sponsor:
University of Southern California
Conditions:
Glabellar Frown Lines
Eligibility:
All Genders
18+ years
Phase:
EARLY_PHASE1
Brief Summary
The purpose of this study is to compare the efficacy and side effects of Botox and Jeuveau for glabellar lines.
Detailed Description
After being informed about the study and potential risks, all patients given consent will receive Botox on one side of their face and Jueveau on the other. A random number generator will generate a li...
Eligibility Criteria
Inclusion
- Age \> 18
- Willingness to participate in the study and able to provide informed consent
Exclusion
- Inability to follow up for study duration
- Prior neurotoxin injection in the last 4 months
- Prior surgery to the glabellar area
- Any planned aesthetic procedure to the glabellar area during the study period
- Cardiac Patients
Key Trial Info
Start Date :
January 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04715048
Start Date
January 1 2021
End Date
June 1 2025
Last Update
December 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
USC Roski Eye Institute
Los Angeles, California, United States, 90033